RxDoctor Payments Data

Abim Sharma

Medical · Mineola, NYNPI 1356786966

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 864 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Medtronic at 50.8% of the total. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,070in general payments, 2019–2025

Across 864 payments — averaging $26.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Boston Scientific$5K
  • Abbott$4K
  • Biotronik Inc.$632
  • Biosense Webster, Inc.$590
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$325
  • plus $668 from 11 others

What the payments were for

  • Travel & lodging$1,2145%
  • Food & beverage$21,84495%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,070 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.

See all medical providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$17,790
XareltoRivaroxaban12$6,554
Amiodarone Hcl11$151
Cephalexin44$91
Pantoprazole Sodium17$76
ClopidogrelClopidogrel Bisulfate12$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$17,79016 claims
Johnson & JohnsonXarelto$167$6,55412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.

Other medical in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →